The Roar Returns: Wall Street's Iconic 'Merger Monday' Stages a Stunning Comeback
Novartis' Cosentyx Shines in Long-Term Trial, Offering Hope for Chronic Joint Pain Sufferers
A New Dawn for ITP Patients: Telitacicept Shows Remarkable Promise in Autoimmune Disorder
Trump's Biotech Revolution: Unleashing a Staggering $350 Billion Investment Wave